We used fibroblast growth factor-8 (FGF-8), which is frequently overexpressed in breast and prostate cancer [9]–[13], as a ligand and FGFR activator to study the functions of FGFR1, 2 and 3. This evidence concerns the gene FGF8 and prostate cancer.